Victory Capital Management
NVCR icon

Victory Capital Management’s NovoCure NVCR Stock Holding History

Victory Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Buy
12,040
+319
+3% +$4.83K ﹤0.01% 2279
2026
Q1 		$128K Buy
11,721
+159
+1% +$1.99K ﹤0.01% 2250
2025
Q4 		$149K Buy
11,562
+115
+1% +$1.48K ﹤0.01% 2237
2025
Q3 		$148K Sell
11,447
-360
-3% -$4.81K ﹤0.01% 2253
2025
Q2 		$210K Sell
11,807
-118
-1% -$2.06K ﹤0.01% 2239
2025
Q1 		$213K Sell
11,925
-117
-1% -$2.66K ﹤0.01% 2208
2024
Q4 		$359K Sell
12,042
-323
-3% -$6.84K ﹤0.01% 2110
2024
Q3 		$193K Sell
12,365
-148
-1% -$2.68K ﹤0.01% 2233
2024
Q2 		$214K Sell
12,513
-164
-1% -$2.88K ﹤0.01% 2186
2024
Q1 		$198K Sell
12,677
-352
-3% -$5.18K ﹤0.01% 2224
2023
Q4 		$195K Buy
+13,029
New +$174K ﹤0.01% 2240
2021
Q4 		– Sell
-2,420
Closed -$281K – 2828
2021
Q3 		$281K Sell
2,420
-429,934
-99% -$65M ﹤0.01% 2404
2021
Q2 		$95.9M Sell
432,354
-101,708
-19% -$19.8M 0.09% 292
2021
Q1 		$70.6M Buy
534,062
+83,276
+18% +$13.2M 0.07% 397
2020
Q4 		$78M Buy
450,786
+409,159
+983% +$56M 0.09% 351
2020
Q3 		$4.63M Buy
41,627
+8,910
+27% +$712K 0.01% 1213
2020
Q2 		$1.94M Sell
32,717
-1,676
-5% -$110K ﹤0.01% 1438
2020
Q1 		$2.32M Sell
34,393
-30,209
-47% -$2.39M ﹤0.01% 1287
2019
Q4 		$5.44M Buy
64,602
+30,379
+89% +$2.45M 0.01% 1162
2019
Q3 		$2.56M Buy
+34,223
New +$2.74M ﹤0.01% 1364

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Victory Capital Management's NVCR Position: Q2 2026 in Review

Victory Capital Management increased its NovoCure (NVCR) stake by 2.7% in Q2 2026, buying an estimated $4.83K and bringing the position to 12,040 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #2279.

Victory Capital Management first reported a position in NVCR in Q3 2019 and has held it in 20 quarters since. The position peaked at $95.9M in Q2 2021. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Victory Capital Management held 12,040 shares of NovoCure worth $182K as of Q2 2026.
  • Victory Capital Management bought 319 NovoCure shares in Q2 2026, an estimated $4.83K.
  • NovoCure made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2279 holding.
  • Victory Capital Management first reported a position in NovoCure in Q3 2019 and has held it in 20 quarters since.
  • Victory Capital Management's NovoCure position peaked at $95.9M in Q2 2021.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.